clinical trial · NCT00648219
Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg
HealthyOlmesartan Medoxomil Tablets 40 mgBenicar® Tablets 40 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's olmesartan medoxomil 40 mg tablets to Sankyo's Benicar® 40 mg tablets following a single, oral 40 mg (1 x 40 mg) dose administered under fed conditions.
started
Dec 1, 2005
primary completion
Dec 1, 2005
completion
Jan 1, 2006
last updated
Apr 23, 2024
official title
Single-Dose Fed In Vivo Bioequivalence Study of Olmesartan Medoxomil Tablets (40 mg; Mylan) to Benicar® Tablets (40 mg; Sankyo) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol